Background: Open spina bifida is the most complex congenital abnormality co
mpatible with long-term survival. This report outlines the 20- to 25-year o
utcome for our original cohort of patients with a myelomeningocele treated
in a nonselective, prospective manner. Methods: Of the initial 118 children
, 71 patients were available for our most recent review. Nineteen patients
have been lost to follow-up and 28 patients have died. Data were collected
on: motor level, shunt status, education/employment, seizure history, mobil
ity, bladder/bowel continence, tethered cord, scoliosis, latex allergy, pos
terior cervical decompression, tracheostomy and/or gastrostomy tube. Result
s: Mortality (24%) continues to climb into young adulthood. Eighty-six perc
ent of the cohort have cerebrospinal fluid diversion, with 95% having under
gone at least one shunt revision. Thirty-two percent have undergone a tethe
red cord release, with 97% having an improvement or stabilization in their
preoperative symptoms. Forty-nine percent have scoliosis, with 43% eventual
ly requiring a spinal fusion. Sixteen patients (23%) have had at least one
seizure. Eighty-five percent are attending or have graduated from high scho
ol and/or college. More than 80% of young adults have social bladder contin
ence. Approximately 1/3 of patients are allergic to latex, with 6 patients
having experienced a life-threatening reaction. Conclusion: At least 75% of
children born with a myelomeningocele can be expected to reach their early
adult years. Late deterioration is common. One of the greatest challenges
in medicine today is establishing a network of care for these adults with s
pina bifida. Copyright (C) 2001 S. Karger AG, Basel.